Invizyne Technologies Inc. Common Stock
Save
148.27M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Invizyne Technologies, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion.

Similar securities

Based on sector and market capitalization

Report issue